MedPath
NMPA Approval

Esomeprazole Sodium for Injection

国药准字H20244629

August 5, 2024

Drug Information

注射用艾司奥美拉唑钠

注射剂

40mg(按C₁₇H₁₉N₃O₃S计)

化学药品

August 5, 2024

Company Information

Applicant Company

武汉经济技术开发区海特科技园

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用艾司奥美拉唑钠 - NMPA 批准文号 | MedPath